COMPARATIVE ANALYSIS OF BRONCHODILATORY POTENTIAL OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST WITH A BETA 2 RECEPTOR AGONIST
NORTHWEST JOURNAL OF MEDICAL SCIENCES · 2022
DOI: 10.69723/njms.01.03.0279 ↗Kurz gefasst
Fachartikel in der Zeitschrift NORTHWEST JOURNAL OF MEDICAL SCIENCES, 2022. Verfasst von Naila Abrar und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
PPAR-γ is also expressed in the lung epithelium, submucosa, and airway smooth muscle. PPAR-δ is broadly expressed with a regulatory role in energy homeostasis, thermogenesis, keratinocyte proliferation and differentiation. PPAR-α and PPAR-γ have been identified as important immunomodulators having potential as novel anti-inflammatory targets for airway diseases. Thiazolidinediones including Pioglitazone and Rosiglitazone are agonists of the receptor and therefore may possess bronchodilating properties. Salbutamol, a beta 2 agonist being used as a bronchodilator has a number of adverse effects based on which the main idea for this study was postulated. Methodology : An experimental study of one week was carried out at animal house of Northwest School of Medicine, on a total of 24 guinea pigs randomly divided into four groups as Group 1 (Histamine control group), Group 2 (Histamine + Salbutamol), Group 3 (Histamine + Rosiglitazone) and Group 4 (Histamine + Pioglitazone). An isometric volume transducer was used to measure the drug effect on histamine induced contractions of the smooth muscles. Comparisons were made by one way ANOVA with a Tukey's post hoc test.
Results
Both Pioglitazone and rosiglitazone significantly reduced the histamine induced contractions with an efficacy equal to salbutamol. Between the two, Pioglitazone produced more potent effect as compared to rosiglitazone.
Conclusion
Thiazolidinediones significantly reduce histamine induced smooth muscle contractions of, which is comparable to the effect of salbutamol. Key words : PPAR- γ, Thiazolidinediones, Beta 2 receptor, Salbutamol, Histamine
Zitieren
APA
Abrar, N., Khan, M., Farooq, O., Hayat, M., Naz, F., Iftikhar, S. H., & Hussain, A. (2022). COMPARATIVE ANALYSIS OF BRONCHODILATORY POTENTIAL OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST WITH A BETA 2 RECEPTOR AGONIST. NORTHWEST JOURNAL OF MEDICAL SCIENCES. https://doi.org/10.69723/njms.01.03.0279
Vancouver
Abrar N, Khan M, Farooq O, Hayat M, Naz F, Iftikhar SH, et al. COMPARATIVE ANALYSIS OF BRONCHODILATORY POTENTIAL OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST WITH A BETA 2 RECEPTOR AGONIST. NORTHWEST JOURNAL OF MEDICAL SCIENCES. 2022. doi:10.69723/njms.01.03.0279
BibTeX
@article{Abrar2022,
author = {Abrar, Naila and Khan, Maaz and Farooq, Omer and Hayat, Mahnoor and Naz, Falak and Iftikhar, Syed Harris and Hussain, Abid},
title = {COMPARATIVE ANALYSIS OF BRONCHODILATORY POTENTIAL OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST WITH A BETA 2 RECEPTOR AGONIST},
journal = {NORTHWEST JOURNAL OF MEDICAL SCIENCES},
year = {2022},
doi = {10.69723/njms.01.03.0279}
}
EUVIMED